-

Incyte to Present at Upcoming Investor Conferences

WILMINGTON, Del.--(BUSINESS WIRE)--Incyte (Nasdaq:INCY) announced today that it will present at the following investor conferences during the month of September:

  • Wells Fargo 2023 Healthcare Conference on Thursday, September 7, 2023 at 8:45 am (EDT)
  • Morgan Stanley 21st Annual Global Healthcare Conference on Monday, September 11, 2023 at 11:20 am (EDT)
  • Bank of America 2023 Global Healthcare Conference on Thursday, September 14, 2023 at 8:15 am (BST)

The presentations will be webcast live and can be accessed at Investor.Incyte.com and will be available for replay for 30 days.

About Incyte

Incyte is a Wilmington, Delaware-based, global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of proprietary therapeutics. For additional information on Incyte, please visit Incyte.com and follow @Incyte.

Contacts

Media
Catalina Loveman
+1 302 498 6171
cloveman@incyte.com

Investors
Gregory Shertzer
+1 302 274 4779
gshertzer@incyte.com

Incyte

NASDAQ:INCY

Release Versions

Contacts

Media
Catalina Loveman
+1 302 498 6171
cloveman@incyte.com

Investors
Gregory Shertzer
+1 302 274 4779
gshertzer@incyte.com

More News From Incyte

Incyte Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

WILMINGTON, Del.--(BUSINESS WIRE)--Incyte Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)...

Incyte and Winnie Harlow Join Forces to Share Her Personal Vitiligo Story and Spark Conversation and Understanding

WILMINGTON, Del.--(BUSINESS WIRE)--Incyte and Winnie Harlow Join Forces to Share Her Personal Vitiligo Story and Spark Conversation and Understanding...

Incyte Appoints Richard Hoffman as Executive Vice President and General Counsel

WILMINGTON, Del.--(BUSINESS WIRE)--Incyte Appoints Richard Hoffman as Executive Vice President and General Counsel...
Back to Newsroom